Recent Updates
Recently added Catalysts
ACH Positive Sentiment

Accendra Health Announces Second Quarter 2026 Earnings Release Date and Conference Call

Monday, July 27, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Accendra Health, Inc. has announced the release date for its second quarter 2026 earnings report, which will be available on August 10, 2026, before market trading begins. The company will also hold a conference call for investors and analysts at 8:00 a.m. EDT on the same day, offering a platform for discussion and inquiries.
Price reaction · baseline $3.14 (2026-07-24 close) · hit pre-market · 1 other ACH headline(s) in the window, move may be shared
day 0 close · peak
+2.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Accendra Health is set to release its financial results.
  • The conference call provides an opportunity for investor engagement.
  • The scheduled date is clearly communicated.

Full Press Release Details

RICHMOND, Va.--(BUSINESS WIRE)--Accendra Health, Inc. (NYSE: ACH) (the “Company”) plans to release financial results for the second quarter of 2026 on Monday, August 10, 2026, before trading begins on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 8:00 a.m. EDT on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058

Frequently Asked Questions

When will Accendra Health release its Q2 2026 earnings?

Accendra Health will release its Q2 2026 earnings on August 10, 2026.

What time is the conference call for Q2 2026 earnings?

The conference call will take place at 8:00 a.m. EDT on August 10, 2026.

How can I access the earnings conference call?

Participants can access the call via a toll-free number or a toll dial-in number.

What is the conference ID for the call?

The conference ID access code is 1058.

ShareAdd on Google
Tags: ACH Viatris Investor Conferences Healthcare Accendra Health earnings release conference call financial results
Last updated: Jul 27, 2026

Biotech snapshot

Cash runway
$8M liquidity · $9M/mo burn
~0 mo
High dilution risk